Mymetics Stock Price, News & Analysis
Company Description
Mymetics (OTC Link: MYMX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $45.0.
MYMX stock has gained 0.0% over the past year. Shares last traded at $0.0003.
On a trailing twelve-month basis, Mymetics reported net income of -$4.7M.
This page provides a comprehensive overview of MYMX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mymetics (MYMX) stock last traded at $0.0003. At a market capitalization of $45.0, MYMX is classified as a micro-cap stock with approximately 151.9K shares outstanding.
Latest News
Mymetics has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all MYMX news →
SEC Filings
Financial Highlights
net income was -$4.7M. The company generated -$1.7M in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
MYMX Company Profile & Sector Positioning
Mymetics (MYMX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MYMX often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Neximmune, Inc. (NEXI), Eloxx Pharmaceut (ELOX), Zim (ZIMCF), and Zivo Bioscience Inc (ZIVO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MYMX's relative position within its industry.